Brind.
  1. Issues surrounding drug effectiveness and regulation are being debated, involving the FDA, WHO, and political figures like Marjorie Taylor Greene and Robert F. Kennedy Jr. in Tennessee.
  2. The intersection of corporate payments, regulatory bodies like the FDA, and the influence of companies like OpenAI on official agendas are being scrutinized.

Allegations of Corporate Influence on Health Agencies Surrounding Robert F. Kennedy Jr.

2 reports, 2 independent Updated Sep 25
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Robert F. Kennedy Jr. received $4 million in book advances over the past year from Skyhorse Publishing, a company owned by Tony Lyons, according to a financial disclosure filed on September 17.

From medicaldaily.com

Why it matters

Some supportBrind's analysis of the reports

Separately, a nonprofit group connected to Robert F. Kennedy Jr. was accused of soliciting payments from companies for access to top U.S. Health and Human Services officials at an upcoming summit.

The intersection of corporate payments, regulatory bodies like the FDA, and the influence of companies like OpenAI on official agendas are being scrutinized.

From latimes.com

Who's involved

  • Robert F. Kennedy Jr.Health and Human Services Secretary under scrutiny regarding financial disclosures and allegations of soliciting payments.
  • Tony LyonsBusiness associate of Robert F. Kennedy Jr. whose company was involved in book deals and group operations.

Keep exploring

Part of

The intersection of corporate payments, regulatory bodies like the FDA, and the influence of companies like OpenAI on official agendas are being scrutinized. All 1 developments

Within Issues surrounding drug effectiveness and regulation are being debated, involving the FDA, WHO, and political figures like Marjorie Taylor Greene and Robert F. Kennedy Jr. in Tennessee.

The entities involved

Related events

Coverage

Newest first; wire copies grouped